Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Efficacy in Ankylosing Spondylitis
NCT01289743Phase 2Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2002
- Primary completion
- Sep 2003
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in ankylosing spondylitis (AS), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT01289743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289743.